メニュー 戻るLS20 Open Innovation in Drug Development in Japan: Preparations in Normal Times, Challenges, and Practices

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS20 Open Innovation in Drug Development in Japan: Preparations in Normal Times, Challenges, and Practices

Session Chair(s)

Makoto Nagaoka, PhD

Makoto Nagaoka, PhD

  • Head of Regulatory Affairs, Japan
  • BeiGene Japan, Japan

Speaker(s)

Kotone Matsuyama, RPh

Kotone Matsuyama, RPh

  • Professor, Department of Health Policy and Management
  • Nippon Medical School, Japan
Keiichi Fukuda, MD, PhD

Keiichi Fukuda, MD, PhD

  • Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics
  • Graduate School of Medicine, Keio University, Japan
Noriatsu Kono, MPharm

Noriatsu Kono, MPharm

  • Organizational management
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Liu Lei

Liu Lei

  • Innovation Partnerships & i2.JP Director
  • AstraZeneca K.K., Japan